An ASO targeting the Scnn1a mRNA that encodes a subunit of the ENaC sodium channel has been tested in cystic fibrosis patients and may also have benefits in other lung diseases characterized by mucus dehydration such as chronic obstructive pulmonary disease (COPD) (65–67). The gene discussed is SCNN1A; the disease is cystic fibrosis.